2Verin P, Easty DL, Secchi A, Ciprandi G, Partouche P, Neraeth WG, et al. Clinical evaluation of twice-daily ernedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis[J]. Am J Ophthalmol 2001, 131(6) : 691-698.
3Leonardi A, DeFranchis G, Fregona IA, Violato D, Plebani M, Secchi AG. Effects of cyclosporin A on human conjunctival fibroblasts[J]. Arck Ophathalmol 2001, 119(10): 1512-1517.
4Gupta V, Sahu PK. Topical cyclosporin A in the management of vernal keratoconjunctivitis[J]. Eye 2001, 15(P1): 3941.
5Mendieute J, Aranzasti C, Eder F, Ostolaza JI, Salaherna M.Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis[J]. Eye 1997, 11 ( P1): 75-78.
6Saini JS, Gupta A, Pandey SK. Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis[J]. Acta Ophthalmol Scand 1999, 77:515-518.
7Akpek EK, Hasiripi H, Christen WG, Kalayei D. A randomized trial of low-dose, topical mitomyein-C in the treatment of severe vernal keratoconjunctivitis [ J ]. Ophthalmology 2000, 107 ( 2 ) : 263-269.
8Leonardi A, Busato F, Fregona I, Plebani M, Secchi AG. Antiinflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model[J ]. Br J Ophthalmol 2000, 4 (11): 1228-1232.
9Nathan H, Naveh N, Meyer E. Levels of prostaglandin E2 and leukotriene 134 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin[J]. Doc Ophthalmol 1994, 85 (3) : 247-257.
10Nishiwaki-Dantas MC, Dantas PE, Pezzutti S, Finzi S. Surgical resection of giant papillae and autologous conjunctival graft in patients with severe vernal keratoconjunctivitis and giant papillae [J]. Ophthal Plast Reconstr Surg 2000,16(6): 438-442.
